Decision Diagnostics Corp (DECN)

[Raffis]

THIS VACCINE WILL NOT BE READY BEFORE GENVIRO IS PRODUCED. AND IT WON’T AFFECT THE NEED FOR TESTS. BUT THIS VACCINE MECHANISM WITH mRNA IS EXACTLY WHAT IS NEEDED FOR AN HIV VACCINE, AS WELL AS OTHERS. THE USE OF A VIRAL PROTEIN SEGMENT FOR ANTIBODY RECOGNITION IS A COMMON METHOD IN VACCINATIONS. THE DANGER IS IN AFFECTING THE HUMAN GENOME AND VIRAL MUTATIONS TO RENDER THE VACCINE USELESS. THESE ARE THE PROS AND CONS OF VACCINATIONS. BUT WE STILL NEED THE TESTS. COVID-19 WILL ALWAYS BE AROUND, BECAUSE IT IS ZOONOTIC. BUT NOBODY IS TALKING ABOUT THAT, BECAUSE SOMETHING’S BEING COVERED UP. NOW READ BELOW:
And so when you put RNA directly into the muscle cell, by injecting it in as a vaccine, that RNA goes right into the cytoplasm [the body, not the nucleus] of the cell, is translated by the ribosomes to make a protein. And in our case, the mRNA that we use to make this protein is our vaccine. And when that RNA goes into the muscle cell, it creates and produces a protein, and when that protein is sitting on the muscle cell, it looks just like the protein that would be sitting on a virus, except we don't have to give it the whole virus, we just give it the protein. And this is the main point of attack; the immune system recognizes this, it starts making antibodies to different surfaces on this protein. And then we count on those antibodies to be present if the virus ever shows up with this same exact protein on its surface. That's the way this mRNA vaccine is working.
https://www.cnn.com/2020/07/24/health/moderna-vaccine-barney-graham-gupta/index.html